Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 106,698 | 186,426 | 193,241 | 202,771 | 182,790 |
| Receivables | 166,345 | 105,844 | 148,999 | 90,098 | 93,156 |
| Inventories | 80,146 | 17,394 | 17,358 | 19,595 | 15,498 |
| TOTAL | $363,638 | $315,543 | $363,238 | $318,532 | $296,311 |
| Non-Current Assets | |||||
| PPE Net | 20,202 | 19,491 | 19,629 | 19,555 | 19,760 |
| Intangibles | 826,311 | 268,723 | 285,518 | 302,314 | 319,109 |
| Other Non-Current Assets | 35,990 | 88,320 | 73,418 | 73,334 | 10,885 |
| TOTAL | $882,503 | $376,534 | $378,565 | $395,203 | $349,754 |
| Total Assets | $1,246,141 | $692,077 | $741,803 | $713,735 | $646,065 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 100,000 | 48,353 | 48,135 | 47,919 | 47,705 |
| Accounts payable and accrued liabilities | 3,851 | 4,189 | 7,730 | 7,543 | 8,666 |
| Accrued Expenses | 268,544 | 226,210 | 212,315 | 170,610 | 173,047 |
| TOTAL | $373,573 | $279,566 | $268,973 | $226,843 | $230,168 |
| Non-Current Liabilities | |||||
| Long Term Debt | 528,390 | 61,666 | 73,832 | 85,944 | 98,006 |
| Other Non-Current Liabilities | 148,102 | 147,917 | 147,904 | 147,882 | 147,856 |
| TOTAL | $676,492 | $209,583 | $221,736 | $233,826 | $245,862 |
| Total Liabilities | $1,050,065 | $489,149 | $490,709 | $460,669 | $476,030 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 33,973 | 33,378 | 34,569 | 35,564 | 35,248 |
| Common Shares | 36 | 36 | 36 | 36 | 35 |
| Retained earnings | -269,411 | -256,342 | -231,308 | -239,354 | -312,197 |
| Other shareholders' equity | 139 | 139 | -480 | 0 | 0 |
| TOTAL | $196,076 | $202,928 | $251,094 | $253,066 | $170,035 |
| Total Liabilities And Equity | $1,246,141 | $692,077 | $741,803 | $713,735 | $646,065 |